Publikationen


Bonelli RM. Religiosität in der wissenschaftlichen Forschung. in: Claudia Schmidt-Hahn (Hrsg.): ORIENTierung: Disputationes Ouvertüre spirituelle, 2014, im Druck

van Duijn E, Craufurd D, Hubers A, Giltay EJ, Bonelli RM, Rickards H, Anderson K, van Walsem M, van der Mast R, Orth M, Landwehrmeyer GB. Neuropsychiatric symptoms in a European Huntington’s disease cohort. Journal of Neurology, Neurosurgery & Psychiatry 2014, accepted

Utsch M, Bonelli RM, Pfeifer S. Psychotherapie und Spiritualität - Mit existenziellen Konflikten und Transzendenzfragen professionell umgehen. Springer-Verlag Berlin. 2014, 228 S. 10 Abb. ISBN 978-3-642-02523-5. Link
REGISTRY Investigators of the European Huntington’s Disease Network. Suicidal ideation in a European Huntington´s disease population. J Affect Disord. 2013 Oct;151(1):248-58. Abstract (engl.)

REGISTRY Investigators of the European Huntington’s Disease Network. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS One. 2013 Jul 22;8(7):e68951. doi: 10.1371/journal.pone.0068951. Print 2013. Abstract (engl.)

Michl M, Schnopfhagen K, Bonelli RM. Pridopidine in the pharmacological treatment of Huntington’s disease. Clinical Investigation July 2013, Vol. 3, No. 7, Pages 691-699 , DOI 10.4155/cli.13.54 Abstract (engl.)

Bonelli RM. Evindenz-basierte Untersuchung zur Rolle der Religiosität in der Psychiatrie. Imago hominis 2013; 20(2): 133-142. Abstract

Bonelli RM, Koenig HG. Mental disorders, religion and spirituality 1990 to 2010: a systematic evidence-based review. J Relig Health. 2013 Jun;52(2):657-73. doi: 10.1007/s10943-013-9691-4. Abstract (engl.)

Bonelli RM. Selber Schuld! Ein Wegweiser aus seelischen Sackgassen. Pattloch-Verlag München. ISBN 978-3-629-13028-0. Link
Vasegh S, Rosmarin DH, Koenig HG, Dew RE, Bonelli RM. Religious and Spiritual Factors in Depression. Depression Research and Treatment 2012, Article ID 298056, 2012. doi:10.1155/2012/298056. Article (engl.)

Reininghaus E, Reininghaus B, Fitz W, Hecht K, Bonelli RM. Sexual behavior, body image and partnership in chronic illness, a comparison of Huntington’s disease and Multiple Sclerosis. Journal of Nervous and Mental Disease 2012 Aug;200(8):716-20. Abstract (engl.)

Bonelli RM, Beal MF. Huntington’s Disease. In: Schlaepfer and Nemeroff (ed): Neurobiology of psychiatric disease, Volume 105 Chapter 30. In: Handbook of Clinical Neurology 2012;106:507-26. Abstract (engl.)

Bonelli RM. Verbitterung und Vergebung in: Hefti R & Bee J (Hrsg) Spiritualität und Gesundheit. Ausgewählte Beiträge im Spannungsfeld zwischen Forschung und Praxis. Peter Lang-Verlag, Berlin 2012. Link

REGISTRY study of the European Huntington´s Disease Network. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012 Mar 6;78(10):690-5. Abstract (engl.)

Bonelli RM, Dew RE, Koenig HG, Rosmarin DH, Vasegh S. Religious and Spiritual Factors in Depression: Review and Integration of the Research. Depression Research and Treatment 2012, Article ID 962860, 8 pages, 2012. doi:10.1155/2012/962860. Article (engl.)

Handley OJ , van Walsem M, Juni P, Bachoud-Levi AC, Bentivoglio AR, Bonelli RM, Burgunder JM, Ferreira J, Heiberg A, Nielsen J, Päivärinta M, Pålhagen S, Ramos-Arroyo M, Roos RA, Tabrizi S, Klempíř J, Vandenberghe W, Verellen-Dumoulin C, Zaremba J, Giuliano J, Biunno I, Dunnett S, Illmann T, Pro Kovisto S, Levey J, Landwehrmeyer BG. Study Protocol of Registry – version 3.0 – European Huntington’s Disease Network (EHDN). Hygiene Public Health 2012, in press

European Huntington’s Disease Network. Discrepancies in reporting the CAG repeat lengths for Huntington´s disease. Eur J Hum Genet. 2012 Jan;20(1):20-6.
European Huntington´s Disease Network. Observing Huntington´s disease: the European Huntington´s Disease Network´s REGISTRY. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12.

REGISTRY Investigators of the European Huntington´s Disease Network. NMDA receptor gene variations as modifiers in Huntington disease: a replication study. PLoS Curr. 2011 Oct 4;3:RRN1247.

Bär KJ, Bonelli RM, Burgunder JM, Dose M, Epplen JT, Jung HH, Kosinski C, Landwehrmeyer B, Priller J, Reilmann R, Saft C, Seppi K, Töpper R. Leitlinie „Chorea“ der Deutschen Gesellschaft für Neurologie (DGN). 2011, link

Holl AK, Ille R, Wilkinson L, Otti DV, Hödl E, Herranhof B, Reisinger KM, Müller N, Painold A, Hödl EM, Bonelli RM. Impaired ideomotor limb apraxia in cortical and subcortical dementia: a comparison of Alzheimer´s and Huntington´s disease. Neurodegenerative Diseases 2011;8(4):208-15.

Painold A, Anderer P, Holl AK, Letmaier M, Saletu-Zyhlarz GM, Saletu B, Bonelli RM. EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington´s disease. Journal of Neurology 2011, May;258(5):840-54.

Painold A, Anderer P, Holl AK, Letmaier M, Saletu-Zyhlarz GM, Saletu B, Bonelli RM. Comparative EEG mapping studies in Huntington´s disease patients and controls. J Neural Transm. 2010 Nov;117(11):1307-18

European Huntington´s Disease Network. Observing Huntington´s Disease: the European Huntington´s Disease Network´s REGISTRY. PLoS Curr. 2010 Sep 28;2. pii: RRN1184.

European HD Network. Factor analysis of behavioural symptoms in Huntington’s disease. J Neurol Neurosurg Psychiatry 2010, in press

Bonelli RM. Internetsexsucht: Sex im World Wide Web. Jatros Neurol Psychiatr 2010 Jun 27(4): 234-7

Holl AK, Wilkinson L, Painold A, Holl EM, Bonelli RM. Combating depression in Huntington´s disease: effective antidepressive treatment with venlafaxine XR. Int Clin Psychopharmacol. 2010 Jan;25(1):46-50.

Bonelli RM. Trauma: Verletzung, Verbitterung, Vergebung. Jatros Neurol Psychiatr 2010 Feb 27(1): 44-46

Painold, A; Anderer, P; Holl, AK; Letmaier, M; Saletu-Zyhlarz, GM; Bonelli, RM; Saletu, B. Electrophysiological Neuroimaging in Huntington’s Disease. 
7th Annual ECNS/ISNIP/ISBET Conference. Abstracts continued from Vol. 41, No. 4, October 2010 issue of Clinical EEG and Neuroscience. 2010; -1st Annual Joint Meeting of the EEG and Clinical Neuroscience Society (ECNS), the International Society for NeuroImaging in Psychiatry (ISNIP) and the International Society for Brain Electromagnetic Topography (ISBET); SEP 14-19, 2010; Istanbul, TURKEY.

Painold, A; Anderer, P; Bonelli, RM; Saletu, B. Influences of co-medication on electrophysiological neuroimaging findings in Huntington´s Disease. 
IPEG 2010; -16th Biennial International Pharmaco-EEG Group (IPEG) Congress; OCT 7–10, 2010; Prague, CZECH REPUBLIC.
Bonelli RM, Prat EH, Bonelli J. Philosophical Considerations on Brain Death and the Concept of the Organism as a Whole. Psychiatria Danubina 2009 Mar;21(1):3-8.

Ortuño F, Arbizu J, Soutullo AC, Bonelli RM. Is there a Cortical Blood Flow redistribution pattern related with Perseverative Error in Schizophrenia? Psychiatria Danubina 2009 Sep;21(3):283-9.

EHDN Registry Study Group. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. Neurology. 2009 Oct 20;73(16):1280-5.
Brandt GN, Bonelli RM. Structural neuroimaging of the basal ganglia in schizophrenic patients: a review. Wiener Medizinischen Wochenschrift 2008 Feb;158(3-4):84-90.

Schmidt EZ, Bonelli RM. Sexuality in Huntington´s disease. Wiener Medizinischen Wochenschrift 2008 Feb;158(3-4):78-83.

Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist. 2008 Mar;14(2):100-7.

Hödl AK, Hödl E, Otti DV, Herranhof B, Ille R, Bonelli RM. Ideomotor limb apraxia in Huntington´s disease: a case-control study. Journal of Neurology. 2008 Mar;255(3):331-9.


Berchtold, N; Thiemann, V; Gadler, HP; Hodl, AK; Kapfhammer, HP; Bonelli, RM (2008): Syntactic changes in Huntington´s disease J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A9-A10.

Berchtold, N; Thiemann, V; Galder, HP; Hödl, AK; Kapfhammer, HP; Bonelli, RM (2008): Analyse der Sprache bei Chorea Huntington ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Friedl, JC; Rafling,C;Siegl CM;Reisinger,KM;Bonelli,RM (2008): Agression in depressed inpatients. 48th INPC Pula 2008; JUN 18-21, 2008; Pula. 2008.

Friedl, JC; Rafling,C;Siegl,CM;Reisinger,KM; Bonelli,RM (2008): Sexualität bei psychiatrischen Erkrankungen:Ein Vergleich zwischen Borderline Persönlichkeitsstörung, Angst-und Panikattacken und Schizophrenie. ÖGPP2008,Toscana Congress Gmunden; APR 23-26,2008; Gmunden. 2008.

Hafenscherer, R; Hodl, AK; Kapfhammer, HP; Bonelli, RM (2008): Huntington´s disease resembling schizophrenia: A case report J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A13-A13.

Koppitz, MW; Reisinger, KM, Hödl, AK; Kapfhammer, HP; Bonelli, RM (2008): Der Einfluss von Psychopharmaka auf die Urodynamik bei Chorea Huntington ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Koppitz, MW; Reisinger, KM; Hodl, AK; Kapfhammer, HP; Bonelli, RM (2008): The influence of psychopharmacological medication on urodynamics in patients with Huntington´s disease J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A16-A17.

Magnet, MK; Koppitz, MW; Kapfhammer, HP; Bonelli, RM (2008): MR bei Chorea Huntington: Korrelation zwischen Hippocampusatrophie und Neuropsychologischer Performance. ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Muller, NJ; Hodl, AK; Herranhof, BJ; Bonelli, RM (2008): Executive functions in Huntington´s disease J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A9-A9. [Listed in ISI Web of Science]

Müller, NJ; Hödl, AK, Herranhof, BJ; Bonelli, RM (2008): Die Exekutiven Funktionen bei Chorea Huntington ; 2008.

Otti, DV; Hödl, AK; Herranhof, B; Kapfhammer, HP; Bonelli, RM (2008): Die Viskonstruktion der Chroea Huntington im Vergleich zur Parkinson- und Lewy-Body-Demenz. ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Painold, A; Anderer, P; Hodl, AK; Diez, J; Reisecker, F; Kapfhammer, HP; Saletu, B; Bonelli, RM (2008): Mainly affected cortical Brodmann areas and conspicuous power changes in different stages of Huntington´s disease: A study using low resolution brain electromagnetic tomography J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A21-A22. [Listed in ISI Web of Science]

Painold, A; Anderer, P; Hödl, AK; Diez, J; Reisecker, F; Kapfhammer, HP; Saletu, B; Bonelli, RM (2008): EEG-Mapping bei Patienten mit Chorea Huntington. 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA. 2008. [Poster]

Painold, A; Anderer, P; Saletu, B; Bonelli, RM (2008): Low Resolution Brain Electromagnetic Tomography bei Chorea Huntington. 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA. 2008.

Painold, A; Hödl, AK; Kapfhammer, HP; Bonelli, RM (2008): Die Wirkung von Risperidon i.m. auf motorische Parameter von Patienten mit Chorea Huntington. 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA. 2008.

Pöschl, EM; Bonelli, RM (2008): Psychiatry in Huntington´s disease J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A13-A13. [Listed in ISI Web of Science]

Pöschl, EM; Bonelli, RM (2008): Psychiatrie der Chorea Huntington: Eine Literaturübersicht ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Pöschl, EM; Kapfhammer, HP; Bonelli, RM (2008): Der Faktor Religiosität in der Evidenz-Basierten Psychiatrie. ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Rafling, C; Friedl, JC; Siegl, CM; Reisinger, KM; Bonelli, RM (2008): Sexualität und Partnerschaft bei depressiven Patienten ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Rafling, C; Friedl,JC;Siegl,CM;Reisinger,KM; Bonelli,RM (2008): Sexuality in psychiatric inpatients:A comparison of patients with Borderline Personality Disorder,Schizophrenia and Anxiety Disorder. 48th INPC Pula 2008; JUN 18-21, 2008; Pula. 2008.

Reisinger, KM; Habermann, W; Hodl, AK; Magnet, M; Bonelli, RM (2008): Dysphagia in Huntington´s disease: A course analysis J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A17-A17.

Reisinger, KM; Habermann,W;Bonelli,RM (2008): Dysphagie bei Patienten mit Chorea Huntington-eine Verlaufsanalyse. 52.Österreichischer HNO-Kongress 2008; SEP 10-14,2008; Graz, Austria. 2008.

Reisinger, KM; Siegl, CM; Friedl, JC; Rafling, C; Bonelli, RM (2008): Aggression bei psychiatrischen Erkrankungen: Ein Vergleich zwischen Borderlinepersönlichkeitsstörungen, Angst- und Panikstörung. ÖGBB Toskana Kongress Gmunden; APR 23-26, 2008; Gmunden, AUSTRIA. 2008.

Schöggl, H; Koppitz, M; Ulla J; Kapfhammer, HP; Bonelli, RM (2008): Besserung der depressiven Symptomatik bei Patienten mit leichter, mittelgradiger und schwerer depressiver Episode in Korrelation zum Plasmaleptinspiegel. ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Siegl, CM; Friedl, JC; Rafling, C; Reisinger, KM; Bonelli, RM (2008): Sexualität bei psychiatrischen Patienten: Ein Vergleich zwischen Borderlinepersönlichkeitsstörung, Angst- und Panikstörung. ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Ullah, J; Hödl, AK; Bonelli, RM; Kapfhammer, HP (2008): Neuropsychiatrische Auffälligkeiten bei Patienten mit Chorea Huntington: Unterschiedliche Wahrnehmung der Symptome durch Patienten und Angehörige. ; 8. Jahrestagung der ÖGPP; APR 23-36, 2008; Gmunden, AUSTRIA.

Ullah, J; Koppitz, M; Hodl, AK; Bonelli, RM; Kapfhammer, HP (2008): Neuropsychiatric aspects of Huntington´s disease: Comparing self-report and caregiver assessment of behavioural changes J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A13-A13. [Listed in ISI Web of Science]
Moreno-Iniguez M, Ortuno F, Bonelli R, Millan M, Soutullo C, Cervera-Enguiz S. Perseverative error in schizophrenia: correlation with cortical blood flow by SPECT. Actas españolas de psiquiatría 2007 Jan-Feb;35(1):20-8.

Bonelli RM, Hofmann P. A systematic review of the treatment studies in Huntington’s disease since 1990. Expert Opinion on Pharmacotherapy 2007 Feb;8(2):141-53.

Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience 2007;9(2):141-51.


Bonelli, RM (2007): Belief and science in psychiatry NERVENARZT. DGPPN 2007; 78: 428-428.

Herranhof BJ, Reisinger KM, Otti DV, Hödl AK, Bonelli RM (2007). Primacy and recency effects in Huntington’s disease. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007 (Santiago/ Chile)

Herranhof BJ, Reisinger KM, Otti DV, Hödl AK, Bonelli RM (2007). Special psychological brain phenomenon’s in Huntington’s disease. Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie und der Österreichischen Gesellschaft für Neurologie und der Österreichischen Alzheimer Gesellschaft. 25. - 28. April 2007 (Salzburg),

Hödl AK, Otti DV, Bonelli RM. Antidepressive treatment of major depression in Parkinson’s disease. 8th International Conference on Alzheimer’s and Parkinson’s diseases. 14. - 18. März 2007 (Salzburg)

Hödl AK, Otti DV, Ille R, Bonelli RM. Apraxia in cortical versus subcortical dementia. 8th International Conference on Alzheimer’s and Parkinson’s diseases. 14. - 18. März 2007 (Salzburg),

Hödl AK, Otti DV, Magnet MK, Bonelli RM. Organic depressive disorder in Huntington’s disease. Effective antidepressive treatment. 8th International Conference on Alzheimer’s and Parkinson’s diseases. 14. - 18. März 2007 (Salzburg)

Hödl AK, Otti DV, Ille R, Bonelli RM. Apraxia in cortical vs. sub cortical dementia. Results from a comparison of Huntington’s disease vs. Alzheimer’s disease. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007

Hödl AK, Otti DV, Ille R, Magnet MK, Lindinger M, Bonelli RM. Gliedmaßenapraxie bei Chorea Huntington und Alzheimer. Ein Vergleich zwischen subkortikaler und kortikaler Demenz. Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie und der Österreichischen Gesellschaft für Neurologie und der Österreichischen Alzheimer Gesellschaft. 25. - 28. April 2007 (Salzburg)

Hödl AK, Reisinger KM, Schöggl H, Painold A, Bonelli RM. Organische Depression bei Chorea Huntington. Antidepressive Behandlung mit Venlafaxin. Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie und der Österreichischen Gesellschaft für Neurologie und der Österreichischen Alzheimer Gesellschaft. 25. - 28. April 2007 (Salzburg)

Hödl AK, Otti DV, Magnet MK, Bonelli RM. Organic depressive disorder in Huntington’s disease. Effective treatment with venlafaxine. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007 (Santiago/ Chile)

Hödl AK, Otti DV, Magnet MK, Bonelli RM. Organic depressive disorder in Huntington’s disease. Effective treatment with venlafaxine. 3nd World Congress of Huntington’s disease. Sep 8th – 11th, 2007 (Dresden/ Germany)

Koppitz M, Magnet MK, Hödl AK, Fian R, Hofmann P, Kapfhammer HP, Bonelli RM. The effect of olanzapine on brain metabolism. April 17th - 21st, 2007 (Santiago/ Chile)

Lindinger MA, Schöggl H, Otti DV, Kapfhammer HP, Bonelli RM. Agression in Huntington’s disease. 8th International Conference on Alzheimer’s and Parkinson’s diseases. 14. - 18. März 2007 (Salzburg)

Magnet MK, Hödl AK, Kapfhammer HP, Bonelli RM. Sertindole Therapy in a case of Huntington’s disease. 8. International Conference on Alzheimer’s and Parkinson’s diseases (AD/PD). 14. - 18. März 2007 (Salzburg)

Magnet MK, Hödl AK, Kapfhammer HP, Bonelli RM. Sertindole Therapy in a case of Huntington’s disease. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007 (Santiago/ Chile)

Magnet MK, Kapfhammer HP, Bonelli RM. MR bei Chorea Huntington: Ein Überblick über die Literatur. Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie und der Österreichischen Gesellschaft für Neurologie und der Österreichischen Alzheimer Gesellschaft. 25. - 28. April 2007 (Salzburg)

Müller N, Hödl AK, Herranhof BJ, Bonelli RM (2007). Executive functions in Huntington’s disease. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007 (Santiago/ Chile)

Müller N, Hödl AK, Herranhof BJ, Bonelli RM (2007). Dysexecutive Syndrome in Huntington’s disease. 3rd World Congress on Huntington’s disease. Sep 8-11, 2007 (Dresden/ Deutschland)

Obermeyer-Pietsch B, Bonelli RM. Knochendichte bei Chorea Huntington. AABP Scientific Meeting. 23. Jänner 2007 (Graz),

Otti DV, Bonelli CM, Hödl AK, Strele A, Obermayer-Pietsch B, Kapfhammer HP, Bonelli RM. Osteoporosis in Huntington’s disease. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007 (Santiago/ Chile)

Otti DV, Bonelli CM, Hödl AK, Strele A, Obermayer-Pietsch B, Kapfhammer HP, Bonelli RM. Bone metabolism in Huntington’s disease. 8. International Conference on Alzheimer’s and Parkinson’s diseases (AD/PD). 14. - 18. März 2007 (Salzburg)

Otti DV, Koppitz M, Obmann S, Magnet M, Hödl AK, Primus G, Kapfhammer HP, Bonelli RM. Urodynamic in Huntington’s disease. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007 (Santiago/ Chile)

Otti DV, Koppitz M, Obmann S, Magnet M, Hödl AK, Primus G, Kapfhammer HP, Bonelli RM. Urodynamic in Huntington’s disease. 3rd World Congress on Huntington’s disease. Sep 8-11, 2007 (Dresden/ Deutschland)

Otti DV, Koppitz M, Obmann S, Magnet M, Hödl AK, Primus G, Kapfhammer HP, Bonelli RM. Urodynamic dysfunction in Huntington’s disease. 8. International Conference on Alzheimer’s and Parkinson’s diseases (AD/PD). 14. - 18. März 2007 (Salzburg)

Painold A, Anderer P, Hödl AK, Diez J, Reisecker F, Kapfhammer HP, Saletu B, Bonelli RM. Low Resolution Brain Electromagnetic Tomography (LORETA) in Patients with Huntington’s disease. April 17th - 21st, 2007 (Santiago/ Chile)

Reisinger KM, Herranhof BJ, Hödl AK, Bonelli RM. MMSE versus kognitiver Bereich des UHDRS in Korrelation zu Alter und Krankheitsstadium bei Chorea Huntington Patienten. Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie und der Österreichischen Gesellschaft für Neurologie und der Österreichischen Alzheimer Gesellschaft. 25. - 28. April 2007 (Salzburg)

Reisinger KM, Herranhof BJ, Hödl AK, Bonelli RM. MMSE versus cognitive subsection of UHDRS correlated with age and stage of illness. 2nd International Congress of Biological Psychiatry. April 17th - 21st, 2007 (Santiago/ Chile)

Hodl AK, Bonelli RM, Kapfhammer HP. Die Gliedmaßenapraxie – Eine Übersicht; Medizinische Klinik; 2006 Jan 15;101(1):24-8.

Bonelli RM, Kapfhammer HP, Pillay SS, Yurgelun-Todd D. Basal Ganglia Volumetric Studies in Affective Disorder: What did we learn in the last 15 years? Journal of Neural Transmission 2006 Feb;113(2):255-68.

Ortuño F, Moreno-Íñiguez M, Millán M, Soutullo CA, Bonelli RM. Cortical Blood Flow during Rest and Wisconsin Card Sorting Test Performance in Schizophrenia. Wiener Medizinischen Wochenschrift 2006 Apr;156(7/8):179-184.

Magnet MK, Kapfhammer HP, Bonelli RM. Cabergoline in Huntington´s disease: the first case report. Acta Neurologica Scandinavica 2006 May;113(5):355-6.

Bonelli RM, Wenning GK. Pharmacological management of Huntington’s disease: an evidence-based review. Current Pharmacological Design 2006;12(21):2701-20.

Pattison LR, Kotter MR, Fraga D, Bonelli RM. Apoptotic cascades as possible targets for inhibiting cell death in Huntington’s disease. Journal of Neurology 2006 Sep;253(9):1137-42.


Bonelli RM, Kapfhammer HP. Psychosoziale und psychiatrische Konsequenzen von schweren, intensivpflichtigen somatischen Erkrankungen. Symposion S-114: Anpassungsreaktionen und depressive Störungen in der somatischen Medizin. DGPPN Kongress. 22. - 25. November 2006 (Berlin/ Deutschland), Vortrag (Nr. 0553).

Bonelli RM. Dementielle Bilder und Frontalhirn. 6. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. Sektion 2: Gesellschaft für biologische Psychiatrie. 27. - 29. April 2006 (Gmunden).

Bonelli RM. Forschung bei Chorea Huntington. 1.Österreichischer Huntington Kongress, 1. Juli 2006 (Mariazell).

Habermann W, Bonelli RM. Videoschluckaktanalyse bei Patienten mit Chorea Huntington. AABP Scientific Meeting. 12. Dezember 2006 (Graz).

Hödl AK, Kapfhammer HP, Bonelli RM. Die Behandlung von Psychiatrischen und Neurologischen Defiziten mit Aripirazol bei einem Patienten mit Chorea Huntington. 6. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 29. April 2006, (Gmunden).

Magnet MK, Habermann W, Hödl AK, Kapfhammer HP, Bonelli RM. Phoniatrie bei Chorea Huntington. 6. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 29. April 2006 (Gmunden).

Magnet MK, Hödl AK, Kapfhammer HP, Bonelli RM. Chorea Huntington Ambulanz Universitätsklinik für Psychiatrie Graz Fallbericht: Aufklärung eines Patienten. 6. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 29. April 2006 (Gmunden).

Obermayer-Pietsch B, Bonelli CM, Strele A, Hödl AK, Dobnig H, Fahrleitner-Pammer A, Kapfhammer HP, Bonelli RM. Bone mineral density in Huntington’s disease is depending on CAG repeats in the neurotrophic Huntingtin gene, but not on weight or medication. Bone 39 (5): S8-S8 November 2006.

Otti DV, Obmann S, Magnet MK, Hödl AK, Kapfhammer HP, Bonelli RM. Blasenfunktionsstörungen bei Chorea Huntington. 6. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 29. April 2006 (Gmunden).

Schmidt EZ, Bonelli RM. Liquor-Tau und Aß42 bei Chorea Huntington. 6. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 29. April 2006 (Gmunden).
Bonelli RM, Hödl AK, Kapfhammer HP. Neuroprotection in Huntington’s disease. Letters in Drug Design & Discovery. 2005 Mar,2:143-147.

Schmidt EZ, Kapfhammer HP, Bonelli RM. Antipsychotic drug holiday in Huntington’s disease. Annals of Pharmacotherapy. 2005 Apr;39(4):773-774.

Schmidt EZ, Hofmann P, Niederwieser G, Kapfhammer HP, Bonelli RM. Sexuality in Multiple Sclerosis. Journal of Neural Transmission. 2005 Sep;112(9):1201-11.

Ortuño F, López P, Landecho I, Bonelli RM. Strong Mixed-Handedness in Schizophrenia. International Journal of Psychiatry in Clinical Practice 2005 Jun;9(2):149-151.

Hödl AK, Bonelli RM. Huntington´s disease and minocycline. Movement Disorders 2005 Apr;20(4):510-1.

Hödl AK, Bonelli RM, Kapfhammer HP. Mild cognitive impairment. Münchner Medizinische Wochenschrift. 2005 Jun 9;147(23):40-3.

Bonelli RM, Hofmann P, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G, Kapfhammer HP. The Influence of Psychotropic Drugs on Cerebral Cell Death: Female Neurovulnerability to Antipsychotics. International Clinical Psychopharmacology 2005 May;20(3):145-149.

Hödl AK, Bonelli RM. Chorea Huntington– Ätiologie, Klinik und Therapie. Psychiatrie und Psychotherapie 2005, 1(1):3-9.
Working Group on Atypical Parkinsonism. Placebo-controlled trial of amantadine in multiple system atrophy. Clinical Neuropharmacology 2005 Sep/Oct;28(5):225-227.

Hödl AK, Bonelli RM. Subcortical dementia in Huntington’s disease. Dementia 2005, 7(3):4-5.

Moreno-Iniguez M, Ortuno F, Arbizu J, Millan M, Soutullo C, Bonelli RM, Cervera-Enguix S. Regional cerebral blood flow SPECT study, at rest and during Wisconsin Card Sorting Test (WCST) performance, in schizophrenia naive patients or treated with atypical neuroleptics.. Actas españolas de psiquiatría 2005 Nov-Dec;33(6):343-51.

Bonelli RM. Psychotherapeutischer Umgang mit dem gerontologischen Patienten. Psychotherapie in Psychiatrie, Psychotherapeutischer Medizin und Klinischer Psychologie 2005 Dec; 10(2): 217-222.

Bonelli RM. Religiosität in der modernen Psychiatrie. Imago hominis 2005 Dec; 12(4): 263-277.


Bonelli RM, Otti DV, Hödl AK, Wenning GK. Subcortical mild cognitive impairment: A novel concept of mental dysfunction. Movement Disorders 20: S130-S130 Suppl. 12. August 2005.

Bonelli RM. MRI findings in bipolar patients. 8. Internationaler Kongress für biologische Psychiatrie. June 28th- July 3rd 2005 (Wien).

Brandt GN, Magnet MK, Kapfhammer HP, Bonelli RM. Basalganglien bei Unipolarer Depression: Übersicht über die volumetrischen MRI-Studien. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 30. April 2005 (Gmunden).

Brandt GN, Magnet MK, Kapfhammer HP, Bonelli RM. Strukturelles MRI der Basalganglien bei Schizophrenie: Eine Übersicht über die Literatur. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 30. April 2005 (Gmunden).

Brandt GN, Magnet MK, Kapfhammer HP, Bonelli RM. Übersicht über die volumetrischen MRI-Studien der Basalganglien bei Bipolarer Störung. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 27. - 30. April 2005 (Gmunden).

Hödl AK, Bonelli RM. Aripiprazole in the treatment of Huntington’s disease: A case report. Journal of Neurology Neurosurgery and Psychiatry 76: Suppl. 4 October 2005.

Hödl AK, Hödl E, Ille R, Bonelli RM. Assessment of limb apraxia in Huntington’s disease. Journal of Neurology Neurosurgery and Psychiatry 76: Suppl. 4. October 2005.

Hödl AK, Kapfhammer HP, Hofmann P, Bonelli RM. Risperidon i.m. Depot bei Chorea Huntington. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30. April 2005 (Gmunden).

Hödl AK, Magnet MK, Bonelli RM. Aripiprazole in the Treatment of Huntington’s disease- A case report. International Huntington Congress. September 10th - 13th 2005 (Manchester/ England).

Hödl AK, Magnet MK, Ille R, Bonelli RM. Assessment of limb Apraxia in Huntington’s disease. International Huntington Congress. September 10th -13th 2005 (Manchester/ England).

Hödl AK, Magnet MK, Ille R, Bonelli RM. Neuropsychological Assessment of Apraxia in Huntington’s disease. 8. Internationaler Kongress für biologische Psychiatrie. 28. Juni - 03. Juli 2005 (Wien).

Hödl AK, Magnet MK, Kapfhammer HP, Bonelli RM. Limb Apraxia and Subcortical Dementia: Neuropsychological Findings. 8. Internationaler Kongress für biologische Psychiatrie. 28. Juni - 03. Juli 2005 (Wien).

Hödl AK. Die Gliedmaßenapraxie. Österreichische Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30.Mai 2005 (Gmunden).

Magnet M, Hödl AK, Kapfhammer HP, Bonelli RM. Dysphagie bei Chorea Huntington. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30. April 2005 (Gmunden).

Magnet MK, Höld AK, Hofmann P, Kapfhammer HP, Bonelli RM, Habermann W. Dysphagia in Huntington’s disease. Journal of Neurology Neurosurgery and Psychiatry 76: Suppl. 4 October 2005.

Magnet MK, Hödl AK, Kapfhammer HP, Bonelli RM. Amantadine in Akinetic Rigid Huntington’s disease. 8. Internationaler Kongress für biologische Psychiatrie. 28. Juni - 03. Juli 2005 (Wien).

Magnet MK, Hödl AK, Kapfhammer HP, Bonelli RM. Cabergoline in Huntington’s disease: The first case report. 8. Internationaler Kongress für biologische Psychiatrie. 28. Juni - 03. Juli 2005 (Wien).

Magnet MK, Hödl AK, Hofmann P, Kapfhammer HP, Habermann W, Bonelli RM. Dysphagia in Huntington’s disease. Journal of Neurology Neurosurgery and Psychiatry 76: Suppl. 4. October 2005.

Magnet MK, Hödl AK, Otti DV, Reisecker F, Kapfhammer HP, Bonelli RM. Vonsattel’s Neuropathological Criteria on MRI in HD. 8. Internationaler Kongress für biologische Psychiatrie. 28. Juni- 03. Juli 2005 (Wien).

Magnet MK, Hödl AK, Otti DV, Reisecker F, Kapfhammer HP, Bonelli RM. Gradeinteilung der Neurodegeneration bei Chorea Huntington mittels MR. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30. April 2005 (Gmunden).

Magnet MK, Kapfhammer HP, Bonelli RM. Amantadin-Therapie bei Akinetisch-Rigider Chorea Huntington. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30. April 2005 (Gmunden).

Magnet MK, Kapfhammer HP, Bonelli RM. Cabergolin-Therapie bei Chorea Huntington. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30. April 2005 (Gmunden).

Otti DV, Hödl AK, Kapfhammer HP, Bonelli RM. Demenz vom Alzheimer Typ und die Rey-Osterrieth Complex – Figure (ROCF): Visuokonstruktive Gedächtnisdefizite. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30. April 2005 (Gmunden).

Otti DV, Hödl AK, Kapfhammer HP, Bonelli RM. Rey-Osterrieth Complex - Figure (ROCF): Visuokonstruktive Gedächtnisdefizite bei Chorea Huntington. 5. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 28. - 30. April 2005 (Gmunden).
Tribl GG, Asenbaum S, Happe S, Bonelli RM, Zeitlhofer J, Auff E. Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep. Nuclear Medicine Communications 2004 Jan;25(1):55-60.

Hofmann P, Bonelli RM. Psychiatrische Aspekte des Rauchens. Imago hominis 2004 Jan;11(1):43-54.

Bonelli RM, Wenning GK, Kapfhammer HP. Huntington’s disease: present treatment and future therapeutic modalities. International Clinical Psychopharmacology 2004 Mar;19(2):51-62.

Bonelli RM, Hofmann P. A review of the treatment options for Huntington´s disease. Expert Opinion on Pharmacotherapy 2004 Apr;5(4):767-76.

Anhaus S, Bonelli RM, Niederwieser G, Reisecker F. Transient Hypoglycemic Abducens Palsy. Acta Medica Austriaca 2004 May;31(2):56-7.

Magnet M, Bonelli RM, Kapfhammer HP. Amantadine in the akinetic-rigid variant of Huntington’s Disease. Annals of Pharmacotherapy 2004 Jul-Aug;38(7-8):1194-6.

Bonelli RM. Pharmacotherapy of Huntington’s disease. Thesis (DMedSc), Graz Medical University 2004.

Hofmann P., Bonelli RM. Neuere Entwicklungen in der Pharmakotherapie der akuten Manie. Psychopraxis 2004 Sep; 5: 1-7

Bonelli RM, Hödl, AK, Hofmann P, Kapfhammer HP. Neuroprotection in Huntington´s disease: A Two Year Study on Minocycline. International Clinical Psychopharmacology 2004 Nov;19(6):337-42.


Bonelli RM, Bonelli CM, Hödl AK, Obermayer-Pietsch B, Kapfhammer HP. Bone Mineral Density is decreased in HD patients. Meeting of the European Huntington Network. October 01st- 03rd 2004 (Madrid/ Spain).

Bonelli RM, Hödl AK, Kapfhammer HP, Wenning GK. Psychiatric management of Huntington’s disease: An evidence-based review. Mental Dysfunctions in Parkinson´s disease. October 24th- 27th 2004 (Salzburg).

Bonelli RM, Hödl AK, Kapfhammer HP, Wenning GK. Psychiatric problems and management of Huntington’s disease. Meeting of the European Huntington Network. October 01st- 03rd 2004 (Madrid/ Spain).

Bonelli RM, Hödl AK, Aschoff A, Niederwieser G, Mayr B, Jirikowski G, Kapfhammer HP. Neurotoxicity of antipsychotic drugs in dementia. 3rd Congress of the EUGMS. September 15th-18th 2004 (Vienna).

Bonelli RM, Hödl AK, Hofmann P, Kapfhammer HP. An Open Label Study on Olanzapine in Huntington’s disease. Meeting of the European Huntington Network. October 01st - 03rd 2004 (Madrid/ Spain).

Bonelli RM, Hofmann P, Wenning GK, Hödl AK, Kapfhammer HP. Neurotoxicity of Psychotropic Drugs in Dementia. 3rd Congress of the European Union Geriatric Medicine Society. September 15th- 18th 2004 (Vienna).

Bonelli RM, Hofmann P, Wenning GK, Hödl AK, Kapfhammer HP. Psychiatric Management of Huntington’s disease: An evidence based review. Mental Dysfunction in Parkinson’s disease. October 24th- 27th 2004 (Salzburg).

Bonelli RM, Hofmann P, Wenning GK, Kapfhammer HP. Psychiatric Management of Huntington’s disease: An evidence-based review. 4. Jahrestagung der ÖGPP. 21. - 24. April 2004 (Gmunden).

Bonelli RM, Payer F, Schmidt R, Fazekas F, Kapfhammer HP. Depressed Mood and 99Tcm- HMPAO SPECT: A study on 352 volunteers. 4. Jahrestagung der ÖGPP. 21. - 24. April 2004 (Gmunden).

Bonelli RM. Neuroprotection in Huntington’s disease. Harvard Medical School, Brigham and Women´s Hospital, Neuroapoptosis Laboratory (Dr. Robert M. Friedlander). October 22nd 2004 (Boston/ USA).

Buchinger W, Semlitsch G, Binter G, Bonelli RM, Langsteger W, Lorenz-Wawschinek O, Eber B, Eber O. TSH und Thyreoglobulin als Indikator einer optimalen Jodversorgung. (Graz).

Haitchi-Petnehaszy S, Bonelli RM, Payer F, Schmidt R, Fazekas F, Kapfhammer HP. Conceptional Reasoning and Attention in Functional Neuroimaging. 4. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie, 21. - 24. April 2004. (Gmunden).

Hödl AK, Hofmann P, Kapfhammer HP, Bonelli RM. An Open Label Study on Minocycline in Huntington’s disease. Meeting of the European Huntington Network. October 01st- 03rd 2004 (Madrid/ Spain).

Hödl AK, Kapfhammer HP, Bonelli RM. Apraxia in HD: A review of the literature. Meeting of the European Huntington Network. October 01st- 03rd 2004 (Madrid/ Spain).

Hödl AK, Otti DV, Kapfhammer HP, Bonelli RM. A Clinical Study on Apraxia in HD. Meeting of the European Huntington Network. October 01st- 03rd 2004 (Madrid/ Spain).

Hödl AK, Otti DV, Kapfhammer HP, Bonelli RM. The occurrence of limb apraxia in patients with sub cortical dementia. 3rd Congress of the EUGMS. September 15th- 18th 2004 (Vienna).

Hödl AK, Otti DV, Wenning GK, Kapfhammer HP, Bonelli RM. Neuropsychological Impairment in Huntington’s disease: The Concept of Mild Cognitive Impairment. Meeting of the European Huntington Network. October 01st- 03rd 2004 (Madrid/ Spain).

Hödl, AK, Otti DV, Bonelli RM, Hofmann P, Kapfhammer HP. Apraxie bei Demenzen. 4. Jahrestagung der ÖGPP. 21. - 24. April 2004 (Gmunden).

Hödl AK, Hödl E, Otti DV, Bonelli RM, Kapfhammer HP. Ideomotor limb apraxia in patients with Huntington’s disease. 3rd Congress of the European Union Geriatric Medicine Society, September 15th- 18th 2004 (Vienna).

Hödl AK, Hödl E, Otti DV, Heranhoff B, Kapfhammer HP, Bonelli RM. Limb apraxia in Huntington’s disease. Mental Dysfunction in Parkinson’s disease. October 24th- 27th 2004 (Salzburg).

Hödl AK, Otti DV, Bonelli RM, Hofmann P, Kapfhammer HP. Apraxie bei subkortikaler Demenz und Mischdemenz. 4. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 21. - 24. April 2004 (Gmunden).

Hödl AK, Otti DV, Bonelli RM, Kapfhammer HP. The occurrence of limb apraxia in patients with sub cortical dementia. Mental Dysfunction in Parkinson’s disease. October 24th- 27th 2004 (Salzburg).

Magnet MK, Kürzenberger M, Bonelli RM, Kapfhammer HP. Autonome Störungen bei Chorea Huntington. 4. Jahrestagung der ÖGPP. 21. - 24. April 2004 (Gmunden).

Otti DV, Hödl A, Kapfhammer HP, Bonelli RM. Neuropsychological assessment in cortical and sub cortical dementia: Memory and visuoconstructional abilities. Mental Dysfunctions in Parkinson´s disease. Mental Dysfunction in Parkinson’s disease. October 24th - 27th 2004 (Salzburg).

Otti DV, Hödl AK, Kapfhammer HP, Bonelli RM. Neuropsychological assessment in cortical and sub cortical dementia: Memory and visuoconstructional abilities. Meeting of the European Huntington Network. October 01st - 03rd 2004 (Madrid/ Spain).

Otti DV, Hoedl AK, Kapfhammer HP, Bonelli RM. Neuropsychiatric assessment in cortical and sub cortical dementia: Memory and visual construction abilities. Mental Dysfunction in Parkinson’s disease. Mental Dysfunction in Parkinson’s disease. October 24th - 27th 2004 (Salzburg).

Schmidt EZ, Bonelli RM, Hofmann P, Niederwieser G, Kapfhammer HP. Sexualität bei Chorea Huntington und Multipler Sklerose. 4. Jahrestagung der ÖGPP. 21. - 24. Oktober 2004 (Gmunden).

Schmidt EZ, Bonelli RM, Hofmann P, Niederwieser G, Kapfhammer HP. Sexualität bei Chorea Huntington und Multipler Sklerose. 4. Jahrestagung der ÖGPP. 21. - 24. April 2004 (Gmunden).

Schmidt EZ, Kapfhammer HP, Bonelli RM. Sexuality and Partnership in HD: A review of the literature. Meeting of the European Huntington Network. October 01st - 03rd 2004 (Madrid/ Spain).

Schmidt EZ, Niederwieser G, Kapfhammer HP, Bonelli RM. A Study on Sexuality and Partnership in HD. Meeting of the European Huntington Network. October 01st - 03rd 2004 (Madrid/ Spain).
Bonelli RM. Olanzapine associated seizure. Annals of Pharmacotherapy 2003 Jan;37(1):150-1.

Bonelli RM, Heuberger C, Reisecker F. Minocycline for Huntington’s disease: an open label study. Neurology 2003 Mar 11;60(5):883-4.

Bonelli RM. Mirtazapine in suicidal Huntington’s disease. Annals of Pharmacotherapy 2003 Mar;37(3):452.

Bonelli RM, Niederwieser G, Lahousen T, Hoffmann P. Zotepine in Huntington’s disease. Human Psychopharmacology Clinical & Experimental 2003 Apr;18(3):227-9.

Lahousen T, Bonelli RM,. Hofmann P. Biologische Aspekte der posttraumatischen Belastungsstörung. In: Hofmann P (ed): Posttraumatischen Belastungsstörung. Springer-Verlag, New York 2003.

Hofmann P, Lahousen T, Bonelli RM. Therapie der Posttraumatischen Belastungsstörung. In: Hofmann P (ed): Posttraumatischen Belastungsstörung. Springer-Verlag, New York 2003.

Lahousen T, Bonelli RM,. Hofmann P. Psychopharmakologische Behandlung von Essstörungen. In: Steinbrenner & Schönauer-Cejpek (ed): Essstörungen. Maudrich-Verlag, Wien 2003.

Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, Költringer P, Archelos JJ. . Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. Journal of Neurology 2003 Jun;250(6):672-5.

Mayr BJ, Bonelli RM. Severe headache with venlafaxine withdrawal. Annals of Pharmacotherapy 2003 Jul-Aug;37(7-8):1145-6.

Hofmann P, Bonelli RM, Lahousen T. Moderne Psychopharmaka bei alten Menschen. Psychopraxis 2003 Sep; 5:10-17.

Bonelli RM. Editorial comment--How to treat vascular dementia? Stroke 2003 Oct;34(10):2331-2.

Bonelli RM, Mayr BJ,Niederwieser G, Reisecker F, Kapfhammer HP. Ziprasidone in Huntington’s disease: the first case reports. Journal of Psychopharmacology 2003 Dec;17(4):459-60

Bonelli RM, Kapfhammer HP. Why minocycline is helpful in Huntington’s disease. Journal of Psychopharmacology 2003 Dec;17(4):461.


Aschoff A, Bonelli RM. Tissue transglutaminase in neurodegenerative disorders. European Science Foundation workshop: Protein cross-linking in neuronal inclusions – Transglutaminases in neurodegeneration. 22nd - 25th May 2003. (Hortobagy-Mata/Hungary).

Bonelli RM, Aschoff A, Niederwieser G, Jirikowski G. Neurotoxicity of psychotropic drugs. Clinical Neuropathology 2003 Volume 22, No. 2/2003 (March/April).

Bonelli RM, Bonelli CM, Niederwieser G, Obermayer-Pietsch B. Huntington’s disease and bone mineral density. Clinical Neuropathology 2003, Volume 22, No. 2/2003 (March/April).

Bonelli RM, Hödl AK, Otti DV, Wenning GK, Kapfhammer HP. Sub cortical Mild Cognitive Impairment in Huntington’s disease. World Congress on Huntington´s disease. August 16th - 19th, 2003 (Toronto/Canada).

Bonelli RM, Hödl A, Otti DV, Wenning GK. Sub cortical Mild Cognitive Impairment: A novel concept of mental dysfunction. International Meeting on Atypical Parkinsonian Disorders: From protein dysfunction to therapeutic intervention. February 19th- 21st 2003 (Innsbruck).

Bonelli RM, Hödl AK, Otti DV, Wenning GK, Kapfhammer HP. Subcortical Mild Cognitive Impairment in Huntington’s disease. World Congress on Huntington´s disease, 16th – 19th August 2003 (Toronto/ Canada).

Bonelli RM, Hoedl A, Otti DV, Wenning GK. Sub cortical Mild Cognitive Impairment: A novel concept of mental dysfunction. Movement Disorders 2003, P45 Suppl.

Bonelli RM, Kapfhammer HP. Antidepressive Behandlung der Depression beim KHK-Patienten. 23. Symposion der AGNP. 08. - 11. Oktober 2003 (München/Deutschland).

Bonelli RM, Niederwieser G, Heuberger C, Reisecker F. A 6 months pilot study on minocycline in Huntington´s disease. Clinical Neuropathology 2003 Volume 22, No. 2/2003 (March/April).

Bonelli RM, Payer F, Kapeller P, Schmidt R, Fazekas F. Depressed Mood Influences Cerebral Blood Flow in Non Demented Volunteers. 6th International Conference AD/PD. May 8th - 12th 2003 (Sevilla/Spain).

Bonelli RM, Payer F, Kapeller P, Schmidt R, Fazekas F. Neuropsychological correlates of 99Tcm- HMPAO SPECT: A study of 362 normal volunteers. 6th International Conference AD/PD. May 8th - 12th 2003 (Sevilla/Spain).

Bonelli RM, Seppi K, Kapfhammer HP, Wenning GK. Magement of Huntington’s disease: An evidence-based review. World Congress on Huntington´s disease. August 16th - 19th, 2003 (Toronto/Canada).

Bonelli RM. Antidepressive Behandlung der Depression beim Parkinson-Syndrom. Experten Meeting Parkinson. 10. - 12. Oktober 2003 (Triest/Italien).

Bonelli RM. Antipsychotika und ihre Neurotoxizität bei Alzheimer Erkrankung. VIII Austrian Neuroscience Winter Meeting. 22nd - 25th March 2003 (Kitzbühel).

Bonelli RM. Weibliche Neurovulnerabilität auf Neuroleptika. 3. Jahrestagung der ÖGPP. 02. -04.October 2003 (Bad Ischl).

Hödl AK, Bonelli RM. Einführung in die Apraxie. ARGE für angewandte Neurophysiologie. „Videoforum Bewegungsstörungen“. 10. April 2003 (Graz).

Hödl AK, Otti DV, Bonelli RM. Is there a Sub cortical Mild Cognitive Impairment? 6th International Conference AD/PD. May 8th - 12th 2003 (Sevilla/Spain).

Lahousen T, Bonelli RM. Neuroprotection in Huntington’s disease (vol 26, pg 223, 2003). Clinical Neuropharmacology 26 (6): 330-330 November-Dezember 2003.

Mayr BJ, Anhaus S, Reisecker F, Bonelli RM. Transient Hypoglycemic Abducens Palsy. Clinical Neuropathology 2003, Volume 22, No. 2/2003 (March/April).

Mayr BJ, Bonelli RM, Reisecker F. Dysosmie: Ein Fallbericht. VIII Austrian Neuroscience Winter Meeting. March 22nd - 25th 2003 (Kitzbühel).

Mayr BJ, Mirtler K, Lahousen T, Hoffmann P, Bonelli RM. Severe headache associated with discontinuation of venlafaxine. Clinical Neuropathology 2003, Volume 22, No. 2/2003 (March/April).

Mayr BJ, Schober T, Kleinert R, Bonelli RM, Reisecker F. Eine psychotische Patientin. VIII Austrian Neuroscience Winter Meeting. March 22nd- 25th 2003 (Kitzbühel).

Mirtler K, Lahousen T, Bonelli RM. Venlafaxine in depressive Parkinson’s disease patients: An open label study. Clinical Neuropathology 2003, Volume 22, No. 2/2003 (March/April).

Niederwieser G, Bonelli RM, Sternad H, Buchinger W, Archelos JJ, Multiple Sclerosis and activated protein C resistance. Clinical Neuropathology 2003, Volume 22, No. 2/2003 (March/April).

Niederwieser G, Bonelli RM, Sternad H, Buchinger W, Archelos JJ, Multiple Sclerosis patients with autoimmune thyroiditis have a worse disease course. Clinical Neuropathology 2003, Volume 22, No. 2/2003 (March/April).

Niederwieser G, Bonelli RM, Sternad H, Buchinger W, Archelos JJ, Multiple Sclerosis and Sex Hormones. Clinical Neuropathology 2003, Volume 22, No. 2/2003 (March/April).
Bonelli RM, Niederwieser G, Diez J, Gruber A, Költringer P. Pramipexole ameliorates neurological and psychiatric symptoms in a Westphal variant of Huntington’s disease. Clinical Neuropharmacology 2002 Jan-Feb;25(1):58-60.

Bonelli RM, Niederwieser G. Apraxia of eyelid closure in Huntington’s disease. Journal of Neural Transmission 2002 Feb;109(2):197-201.

Bonelli RM, Gruber A. Deep brain stimulation in Huntington’s disease. Movement Disorders 2002 Mar;17(2):429-30.
Bonelli RM, Niederwieser G, Tribl GG, Költringer P. High-dose-olanzapine in Huntington’s disease. International Clinical Psychopharmacology 2002 Mar;17(2):91-3.

Anhaus S, Bonelli RM, Költringer P, Reisecker F. Craniale Mononeuropathie bei chronischer Hypoglykämie. Aktuelle Neurologie 2002 Mar;29(3):92-94.

Mayr BJ, Bonelli RM, Niederwieser G, Költringer P, Reisecker F. Zolpidem in Progressive Supranuclear Palsy: a Case Report. European Journal of Neurology 2002 Mar;9(2):184-5.

Bonelli RM, Niederwieser G, Diez J, Költringer P. Riluzole and olanzapine in Huntington’s disease. European Journal of Neurology 2002 Mar;9(2):183-4.

Bonelli RM. Ethische Probleme im Umgang mit Chorea Huntington Patienten. Imago hominis 2002 Jul;9(3):171-178.
Bonelli RM, Niederwieser G. Quetiapine in Huntington’s disease: a first case report. Journal of Neurology 2002 Aug;249(8):1114-1115.

Mayr BJ, Bonelli RM, Niederwieser G, Költringer P, Reisecker F. Dysarthrie als Erstmanifestation einer Progressiven Supranukleären Blickparese. Aktuelle Neurologie 2002 Aug;29(7):295-297.

Melinz K, Bonelli RM, Kenner L, Niederwieser G, Reisecker F. Primäres hochmalignes B-Zell-Lymphom des ZNS: Fallpräsentation und Literaturübersicht. Nervenarzt 2002 Aug;73(8):779-84.

Tribl GG, Asenbaum S, Klösch G, Mayer K,. Bonelli RM, Auff E, Zeitlhofer J, Happe S. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2002; Aug 27;59(4):649-50.

Bonelli RM, Mahnert FA, Niederwieser G. Olanzapine for Huntington’s disease: an open label study. Clinical Neuropharmacology 2002 Sep-Oct;25(5):263-5.

Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G. Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer´s disease Tissue transglutaminase activity in vascular dementia. Neurobiology of Disease 2002 Oct;11(1):106-10.

Bonelli RM, Thau K. Lithium. Nervenheilkunde 2002 Oct;21(8):438-444.

Bonelli RM, Aschoff A, Jirikowski G. Tissue transglutaminase activity in vascular dementia. Journal of the Neurological Sciences 2002 Nov 15;203-204(C):207-9.


Aschoff A, Jirikowski G, Niederwieser G, Heuberger C, Bonelli RM. Tissue transglutaminase in Alzheimer’s disease and neuroleptic medication. European Journal of Neuroscience 2002.

Bonelli CM, Bonelli RM, Eichinger M, Suppan K, Reisecker F, Leb G, Obermayer-Pietsch BM. Bone density and bone turnover in Huntington´s disease. Osteoporosis International 13: S64-S64 Suppl. 1, 2002.

Bonelli CM, Bonelli RM, Reisecker F, Krejs H, Obermayer-Pietsch B. Osteoporosis in Huntington’s disease. International Congress on Osteoporosis. May 23rd - 24th 2002 (Lissabon/Portugal).

Bonelli CM, Bonelli RM, Reisecker F, Krejs H, Obermayer-Pietsch B. Osteoporose bei Chorea Huntington. Osteology 2002. 6. - 10. März 2002 (Graz).

Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Diez J, Jirikowski G. CSF-Tissue transglutaminase in VaD and AD. Second International Congress on Vascular Dementia. January 24th- 27th 2002 (Salzburg).

Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G. Neurotoxicity of antipsychotic drugs in Alzheimer´s disease. European Neuropsychopharmacology12: S366-S367 Suppl. 3, October 2002.

Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G. Neurotoxicity of antipsychotic drugs in Alzheimer´s disease. European Neuropsychopharmacology12: S366-S367 Suppl. 3, October 2002.

Bonelli RM, Aschoff A, Niederwieser G, Jirikowski G. Neurotoxicity of antipsychotic drugs in Alzheimer’s disease. European Journal of Neurology 2002 October; 9(suppl 2): 34, Abstract SC 227.

Bonelli RM, Bonelli CM, Obermayer-Pietsch B. Osteoporosis in Huntington´s disease due to neuroleptic medication? European Neuropsychopharmacology 12: S367-S367 Suppl. 3, October 2002 Abstract P4.005.

Bonelli RM, Bonelli CM, Obermayer-Pietsch B, Reisecker F. Bone Mineral Density in Huntington´s disease. European Journal of Neurology 2002 October; 9(suppl 2): 206, Abstract P3155.

Bonelli RM, Bonelli CM, Obermayer-Pietsch B. Osteoporosis in Huntington´s disease. Neurology 2002 (Apr 9) 58 (7): A307-A308 Suppl. 3.

Bonelli RM, Lahousen T, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G. Neurotoxicity of Antipsychotic Drugs in Alzheimer’s disease. European Neuropsychopharmacology 2002 October; 12(suppl 3): S366, Abstract P4.003.

Bonelli RM, Lahousen T, and Hofmann P. Olanzapine for Huntington’s disease: An open label study. European Neuropsychopharmacology 2002 October; 12(suppl 3): 367, Abstract P4.005.

Bonelli RM, Lahousen T, Niederwieser G. Is Olanzapine the treatment of Choice in Huntington’s disease? European Journal of Neurology 2002 October; 9(suppl 2): 206, Abstract P3154.

Bonelli RM, Lahousen T. Neuroprotection in Huntington’s disease: Minocycline. European Neuropsychopharmacology 2002 October; 12(suppl 3): 367, Abstract P4.006.

Bonelli RM, Niederwieser G, Reisecker F. Minocycline as Neuroprotection in Huntington’s disease. European Journal of Neurology 2002 Oct; 9(suppl 2): 200, Abstract P 3133.

Bonelli RM. A rare case of resting tremor. 3rd Taskforce Meeting Atypical Parkinsonian Syndromes of the Austrian Parkinson’s Disease Society. September 10th - 11th 2002 (Pörtschach), Videosession.

Bonelli RM. Psychogener Tremor. ARGE für angewandte Neurophysiologie. „Videoforum Bewegungsstörungen“. 6. März 2002 (Graz).

Buchinger W, Niederwieser G, Bonelli RM, Höger FS, Reisecker F, Archelos JJ, Költringer P. Multiple sclerosis: Three year surveillance of the thyroid gland under interferon-beta therapy. The Thyroid and Brain. Merck European Thyroid Symposium. May 30th - June 02nd 2002 (Sevilla/Spain).

Diez J, Bonelli RM. Vascular Choreaathetosis. 3rd Taskforce Meeting Atypical Parkinsonian Syndromes of the Austrian Parkinson’s disease Society. September 10th - 11th 2002 (Pörtschach), Videosession.

Hödl AK. Videovortrag: Der apraktische Patient. Österreichische Gesellschaft für Neurophysiologie. Mai 2002 (Graz).
Mayr BJ, Hödl AK, Aschoff A, Bonelli RM. Alzheimer’s disease, cerebrospinal fluid and apoptosis. 3rd Neurobiology of Aging Conference: Molecular and Cellular Basis of Synaptic Loss and Dysfunction in Alzheimer’s Disease. October 31st - November 01st 2002 (Orlando/ USA).

Mayr BJ, Hödl AK, Aschoff A, Bonelli RM. Antipsychotic drugs, cerebrospinal fluid and apoptosis. 3rd Neurobiology of Aging Conference: Molecular and Cellular Basis of Synaptic Loss and Dysfunction in Alzheimer’s disease. October 31st - November 01st 2002 (Orlando/ USA).

Niederwieser G, Bonelli RM, Buchinger W, Höger FS, Reisecker F, Archelos JJ. Multiple sclerosis patients with autoimmune thyroiditis have a worse disease course. European Journal of Neurology 2002 Oct; 9(suppl 2): 220, Abstract P3206.

Niederwieser G, Bonelli RM, Sternad H, Buchinger W, Archelos JJ. Activated protein C resistance in Multiple Sclerosis. European Journal of Neurology 2002 Oct; 9(suppl 2): 136, Abstract P2102.
Niederwieser G, Bonelli RM, Brunner D, Neubauer M, Buchinger W, Reisecker F, Költringer P. Diagnostic accuracy of an agarose gel electrophoretic method in multiple scerosis. Clinical Chemistry 2001, Jan;47(1):144.

Bonelli RM, Reisecker F, Költringer P. Prevention of chronic pain in whiplash injury. Journal of Pain and Symptom Management 2001 Feb;21(2):92-3.

Bonelli RM, Thau K. Noncompliance: ein Überblick. Deutsche Medizinische Wochenschrift 2001 Jun 8;126(23):699-703.
Niederwieser G, Bonelli RM, Reisecker F, Költringer P. Intracerebral haemorrage under interferon-beta therapy. European Journal of Neurology 2001, Jul;8(4):363-4.

Krenn M, Bonelli RM, Niederwieser G, Reisecker F, Költringer P. Adrenoleukodystrophie kann Multiple Sklerose imitieren. Nervenarzt 2001 Oct;72(10):794-7.

Bonelli RM, L Kenner, Gruber A, Reisecker F, Költringer P. Compactotomy in Huntington’s chorea? Medical Hypothesis 2001 Oct;57(4):491-6.

Niederwieser G, Bonelli RM, Pongratz R, Neubauer M, Buchinger W, Kammerhuber F, Reisecker F, Kleinert R, Koltringer P. Cerebral vasculitis associated with Reiter’s syndrome. Journal of Neurology 2001 Nov;248(11):988-9.


Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Gruber A, Jirikowski G. Tissue transglutaminase activity in cerebrospinale fluid in dementing disorders. Aging of the Brain and Dementia. November 23rd - 24th 2001 (Florence/Italy).

Bonelli RM, Bernhard S. Olanzapin bei Chorea Huntington: Ein Fallbericht. ARGE für angewandte Neurophysiologie. „Videoforum Bewegungsstörungen“10. Jänner 2001 (Graz).

Bonelli RM, Diez J, Niederwieser G. Olanzapine in Huntington’s disease. „Alpine Basal Ganglia Club Meeting“. March 1st - 3rd 2001 (Innsbruck).

Bonelli RM, Kenner L, Gruber A, Reisecker F. Deep Brain Stimulation in Huntington’s disease. 19th International Meeting of the World Federation of Neurology Research Group on Huntington’s disease. August 25th - 28th 2001 (Copenhagen/Denmark).

Bonelli RM, Niederwieser G, Diez J. Apraxia of eyelid closure in Huntington’s disease. 19th International Meeting of the World Federation of Neurology Research Group on Huntington’s disease. August 25th - 28th 2001 (Copenhagen/Denmark).

Bonelli RM, Niederwieser G. A Case Report on Eyelid Apraxia. Aging of the Brain and Dementia. November 23rd - 24th 2001 (Florence/Italy).

Bonelli RM, Niederwieser G. Olanzapine, Amisulpride, Quetiapine, Sertindole, and Risperidone in Huntington’s disease. 19th International Meeting of the World Federation of Neurology Research Group on Huntington’s disease. August 25th - 28th 2001 (Copenhagen/Denmark).

Bonelli RM, Niederwieser G. Pramipexole in the Westphal variant of Huntington’s disease. 19th International Meeting of the World Federation of Neurology Research Group on Huntington’s disease. August 25th - 28th 2001 (Copenhagen/Denmark).

Mayr BJ, Bonelli RM. Atypische progressive supranukleäre Blickparese mit initialer Dysarthrie. ARGE für angewandte Neurophysiologie. „Videoforum Bewegungsstörungen“. 10. Jänner 2001 (Graz).

Melinz K, Bonelli RM, Niederwieser G, Költringer P, Reisecker F. Primäres. Hochmalignes B-Zell-Lymphom des ZNS. VI Austrian Neuroscience Winter Meeting. March 14th-17th 2001 (Kitzbühel).

Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Archelos JJ, Költringer P. Prevalence of Thyroid Disease in Multiple Sclerosis. Experimental Biology. March 31st - April 4th 2001 (Orlando/USA).

Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, Archelos JJ, Koltringer P. Prevalence of thyroid disease in Multiple Sclerosis. FASEB Journal 15 (4): A73-A73 Part 1, March 7th 2001.

Niederwieser G, Buchinger W, Bonelli RM, Höger FS, Reisecker F, Archelos JJ, Költringer P. Multiple Sclerosis: Three year surveillance of the thyroid gland under interferon-beta therapy. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). September 12th- 15th 2001 (Dublin/Ireland).

Wieland A, Bonelli RM. Post-stroke hemiballism. ARGE für angewandte Neurophysiologie. „Videoforum Bewegungsstörungen“ 10. Jänner 2001 (Graz).

Bonelli RM, Stoll M, Gatterbauer A. Hypertherme Laser-Doppler-Flowmetrie. Jahrestagung der Österreichischen Gesellschaft für klinische Neurophysiologie. 11. November 2000 (Innsbruck).

Anhaus S, Niederwieser G, Bonelli RM, Reisecker F, Költringer P. Sprachstörungen und Dyskinesien als Initialsymptom einer korticobasalen Degeneration. Nervenarzt 2000; Apr;71(4):311-5.

Gruber A, Roessler K, Georgopoulos A, Mißbichler A, Bonelli R, Richling B. Evaluation of big endothelin – 1 concentrations in serum and ventricular cerebrospinal fluid after early surgical compared with nonsurgical management of ruptured intracranial aneurysms. Journal of Neurosurgery 2000 (May), Neurosurgical Focus, Volume 8, Issue 5 (http://www.neurosurgery.org/focus).

Ortuno F, Bonelli RM. The relevance of Schneider´s first-rank symptoms. British Journal of Psychiatry 2000, Jul;177:85.
Költringer P, Bonelli RM, Mayr BJ, Nitsche H, Sengl T, Reisecker F. Coordination Ability Test. Perfusion 2000 Oct, 13(10):436-438.

Bonelli RM, Költringer P. Autonomic nervous function assessment using thermal reactivity of microcirculation. Clinical Neurophysiology 2000; Oct 1;111(10):1880-1888.

Bonelli RM, Bugram R. Additional A-criterion for adjustment disorders? Canadian Journal of Psychiatry 2000 Oct;45(8):763.
Bonelli RM, Niederwieser G, Stoll M, Gatterbauer A, Reisecker F, Költringer P. Hyperthermal laser-Doppler-flowmetry. Perfusion 2000 Dec, 13(12):528-535.


Bonelli RM, Stoll M, Gatterbauer A. Hypertherme Laser-Doppler-Flowmetrie. Jahrestagung der Österreichischen Gesellschaft für klinische Neurophysiologie. 11. November 2000 (Innsbruck).

Kenner L, Beham-Schmid C, Bonelli RM, Sill H, and Höfler G. Loss of bcl-2 rearrangement in a follicular B-cell lymphoma after high grade transformation 2000 Frühjahrestagung der Deutschen Gesellschaft für Pathologie. 12. April 2000 (Kiel/Germany).

Bonelli RM, A Gruber, Költringer P, Kenner L, Reisecker F. Reversible Huntington´s disease - lesion to the globus pallidus? Lancet 1999 Jan 16;353(9148):240-1.

Bonelli RM, Bonelli J, Költringer P, Kotter M, Kenner L. Psychiatrists´ attitudes to euthanasia. Lancet 1999 Jan 16;353(9148):243-4.

Bonelli J, Prat EH, Auner N, Bonelli RM. Brain death: understanding the organism as a whole. Medicina e Morale 1999; 3: 497-515.

Zalaudek I, Bonelli RM, Költringer P, Reisecker F, K Wagner. Early diagnosis in Duchenne muscular dystrophy. Lancet 1999 Jun 5;353(9168):1975.

Eisemann M, Richter J, Bauer B, Bonelli R, Porzsolt F. Physicians´ decision-making in incompetent elderly patients: a comparative study between Austria, Germany (East, West), and Sweden. International Psychogeriatrics 1999 Sep;11(3):313-24.

Buchinger W, Niederwieser G, Semlitsch G, Bonelli RM, Höger S, Reisecker F, Rainer F. Inzidenz von Immunthyreopathien unter Beta-Interferon-Therapie. Acta Med Austriaca. 1999; 26:15.
Bonelli RM, Költringer P, Kenner L, Reisecker F. Reversible Huntington´s disease? Lancet 1998 Nov 7;352(9139):1520-1.

Bonelli RM. Psychopathologischer Status. In: Bernd Eber, Andrea Sakotnik (ed.): Medizinische Propädeutik; Leykam-Buchverlag Graz 1998; p.20-30.

Bugram R, Bonelli RM. Adjustment disorder in young men serving in the Austrian Army. XXXIInd International Congress on Military Medicine. 1998 (Vienna), Abstract Book No. 045.

Bonelli RM. Das alte Problem mit einem neuen Namen: Noncompliance. Imago hominis 1997; IV(1): 19-30.
Buchinger W, Lorenz-Wawschinek O, Semlitsch G, Langsteger W, Binter G, Bonelli RM, Eber O. Thyrotropin and Thyreoglobulin as an Index of Optimal Iodine Intake: Correlation with Iodine Excretion of 39.913 Euthyreod Patients. Thyroid 1997; 7(4): 593-7.

Bonelli RM. Der Fall einer Flunarizin - ausgelösten, nach Jahren reversiblen choreatischen Symptomatik bei positivem Huntington-Gen und progredienter Demenz. ARGE für angewandte Neurophysiologie. „Videoforum Bewegungsstörungen“. 1. Oktober 1997 (Graz), Vortrag.
Buchinger W, Lorenz-Wawschinek O, Binter G, Langsteger W, Bonelli R, Eber O. Relation between serum thyrotropin and thyroglobulin with urinary iodine excretion. In: J.Naumann, D.Glinoer, L.E.Braverman, U.Hostalek (ed.): The Thyroid and Iodine; Schattauer (Stuttgart) 1996.

Buchinger W, Semlitsch G, Binter G, Bonelli RM, Langsteger W, Lorenz-Wawschinek O, Eber B, Eber O. TSH und Thyreoglobulin als Indikator einer optimalen Jodversorgung. Acta Med Austriaca 1996; 23 (Sonderheft 1):11-12.
Bonelli RM. Compliance in einer Ambulanz für Phasenprophylaxe. Thesis (MD), University of Vienna 1994. 234 pages.
Bonelli RM. Mifepristone. Diskussionsforum Medizinische Ethik (in Wiener Medizinische Wochenschrift) 1992; (6-7):XXXVIII-XLIII.